Peptide Synthesis Market worth $1.54 billion by 2031
The report "Peptide Synthesis Market by Instruments (Synthesizers, Purification, Lyophilizers, Analytical), Reagents (Amino Acids, Resins), Technique (Chemical, Biological), Services (Custom Synthesis, Modification), Application, End User - Global Forecast to 2031", is projected to grow from USD 0.98 billion in 2026 and to reach USD 1.54 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 9.5% during the forecast period.
Browse 900 market data Tables and 55 Figures spread through 565 Pages and in-depth TOC on "Peptide Synthesis Market by Instruments (Synthesizers, Purification, Lyophilizers, Analytical), Reagents (Amino Acids, Resins), Technique (Chemical, Biological), Services (Custom Synthesis, Modification), Application, End User - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/peptide-synthesis-market-158927365.html
The peptide synthesis market is witnessing sustained growth, supported by the expanding pipeline of peptide-based therapeutics, rising demand for GLP-1 and other metabolic peptides, increasing development of peptide-drug conjugates, and continued growth in outsourced peptide synthesis. Demand for efficient, high-purity, and reproducible synthesis is encouraging wider adoption of automated peptide synthesizers, advanced purification systems, and high-quality reagents & consumables across pharmaceutical & biotechnology companies, CROs & CDMOs, academic & research institutes, and diagnostic laboratories. These workflows rely extensively on protected amino acids, resins, coupling and deprotection reagents, solvents, and peptide modification reagents to support complex synthesis requirements. Advances in solid-phase peptide synthesis, microwave-assisted synthesis, continuous-flow technologies, high-throughput automation, purification, and analytical characterization are enabling broader use in therapeutic discovery and research applications. The shift toward longer, cyclic, conjugated, and highly modified peptides is further strengthening demand. In addition, growing reliance on specialized service providers for custom synthesis, peptide engineering, purification, labeling, and analytical services is expected to support continued investment in peptide synthesis technologies and capabilities.
By offering, the products segment accounted for the largest share of the global peptide synthesis market in 2025.
Based on offering, the peptide synthesis market is segmented into products and services. Products accounted for the largest share of the peptide synthesis market in 2025, driven by recurring demand for protected amino acids, resins, coupling and deprotection reagents, solvents, purification consumables, and other synthesis inputs. Demand is also supported by the installed base of peptide synthesizers, purification systems, analytical & quality control instruments, and lyophilizers across pharmaceutical & biotechnology companies, CROs & CDMOs, and academic & research institutes. The recurring nature of reagent and consumable purchases, together with continued adoption of automated synthesis and advanced purification workflows, supports the segment’s leading position.
Biological synthesis is estimated to register the highest growth in the peptide synthesis products market during the forecast period.
The peptide synthesis products market is segmented by technique into chemical synthesis and biological synthesis. During the forecast period, biological synthesis is projected to be the faster-growing technique, supported by increasing interest in recombinant peptide production and enzymatic synthesis for selected long, complex, and difficult-to-synthesize peptides. Enzymatic approaches offer high selectivity and milder reaction conditions, while recombinant platforms provide an alternative route for peptides suited to biological production. However, chemical synthesis, led by solid-phase peptide synthesis (SPPS), remains the dominant technique due to its established workflows, automation, and broad supplier ecosystem.
North America accounted for the largest regional share in the global peptide synthesis market in 2025.
The peptide synthesis market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America accounted for the largest share of the global market, driven by a well-established pharmaceutical and biotechnology industry, strong peptide drug discovery activity, significant life-science R&D spending, and widespread adoption of automated synthesis, purification, and analytical technologies. The region also benefits from major peptide synthesis product suppliers, custom synthesis providers, CROs, and research institutions. Continued development of peptide therapeutics, including metabolic and oncology candidates, further supports the region’s leading market position.
Key players in the peptide synthesis market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), GenScript Biotech Corporation (China), Kaneka Corporation (Japan), Biotage AB (Sweden), Sartorius AG (Germany), Bachem Holding AG (Switzerland), CEM Corporation (US), Bio-Synthesis, Inc. (US), Biosynth (Switzerland), CSBio (US), GL Biochem (Shanghai) Ltd. (China), Mesa Laboratories, Inc. (US), Danaher Corporation (US), Chem-Impex International, Inc. (US), Advanced ChemTech (ACT) (US), Mimotopes Pty Ltd (Australia), Iris Biotech GmbH (Germany), AAPPTec, LLC (US), Enamine Ltd. (Ukraine), Intavis Peptide Services (Germany), JPT Peptide Technologies GmbH (Germany), Innovagen AB (Sweden), Peptide Protein Research Ltd. (UK), LifeTein LLC (US), Creative Peptides (US), Genemed Synthesis, Inc. (US), ChinaPeptides Co., Ltd. (China), and Beijing Scilight Biotechnology Co., Ltd. (China).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Peptide Synthesis Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
